These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 7741403
21. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy. Fjornes T, Wiedemann GJ, Sack K, Jelkmann W. Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299 [Abstract] [Full Text] [Related]
22. [Determination of the standard level of serum erythropoietin in relation to hemoglobin concentration]. Takahashi Y, Yoshida Y, Hara H, Yamaguchi N, Kawagoe H, Shibata H, Teshima H, Ohno Y, Akasaka K. Rinsho Ketsueki; 1993 Apr; 34(4):465-72. PubMed ID: 8510335 [Abstract] [Full Text] [Related]
23. Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes. Depaoli L, Levis A, Isabella N, Ficara F, Priotto C, Lista P, Foà R, Resegotti L. Haematologica; 1993 Apr; 78(2):118-22. PubMed ID: 8349187 [Abstract] [Full Text] [Related]
25. Low serum levels of tumor necrosis factor and interleukin-1 beta in myelodysplastic syndromes responsive to recombinant erythropoietin. Musto P, Matera R, Minervini MM, Checchia-de Ambrosio C, Bodenizza C, Falcone A, Carotenuto M. Haematologica; 1994 Apr; 79(3):265-8. PubMed ID: 7926977 [Abstract] [Full Text] [Related]
26. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Thomas MC, Tsalamandris C, Macisaac R, Jerums G. Diabet Med; 2006 May; 23(5):502-9. PubMed ID: 16681558 [Abstract] [Full Text] [Related]
27. [Erythropoietin in non-specific intestinal inflammation]. Hertlová M, Zboril V, Kautská J, Pokorný A, Prokopová L. Vnitr Lek; 1998 Aug; 44(8):451-5. PubMed ID: 10358447 [Abstract] [Full Text] [Related]
28. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kimata N, Akiba T, Pisoni RL, Albert JM, Satayathum S, Cruz JM, Akizawa T, Andreucci VE, Young EW, Port FK. Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270 [Abstract] [Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial. Vincent JL, Spapen HD, Creteur J, Piagnerelli M, Hubloue I, Diltoer M, Roman A, Stevens E, Vercammen E, Beaver JS. Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233 [Abstract] [Full Text] [Related]
30. Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting. Pradella M, Cavill I, d'Onofrio G. Clin Lab Haematol; 1996 Dec; 18 Suppl 1():35-7. PubMed ID: 9054717 [Abstract] [Full Text] [Related]
31. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma]. Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M. Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596 [Abstract] [Full Text] [Related]
32. Serum immunoreactive erythropoietin during the perioperative period. Clemens J, Spivak JL. Surgery; 1994 Apr; 115(4):510-5. PubMed ID: 8165543 [Abstract] [Full Text] [Related]
33. Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease. Saraf S, Farooqui M, Infusino G, Oza B, Sidhwani S, Gowhari M, Vara S, Gao W, Krauz L, Lavelle D, DeSimone J, Molokie R, Saunthararajah Y. Br J Haematol; 2011 May; 153(3):386-92. PubMed ID: 21418176 [Abstract] [Full Text] [Related]
34. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Bowen DT, Jacobs A, Cotes PM, Lewis TC. Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217 [Abstract] [Full Text] [Related]
35. Serum erythropoietin levels after renal transplantation with various graft outcomes. Ghods AJ, Arghani H, Ghadiri G. Transplant Proc; 1995 Oct; 27(5):2577-8. PubMed ID: 7482834 [No Abstract] [Full Text] [Related]
36. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin. Bowen D, Culligan D, Jacobs A. Br J Haematol; 1991 Mar; 77(3):419-23. PubMed ID: 2012769 [Abstract] [Full Text] [Related]
37. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology. Gowanlock Z, Sriram S, Martin A, Xenocostas A, Lazo-Langner A. PLoS One; 2016 Mar; 11(6):e0157279. PubMed ID: 27310832 [Abstract] [Full Text] [Related]
39. Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia. Leowattana W, Krudsood S, Tangpukdee N, Brittenham G, Looareesuwan S. Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):581-8. PubMed ID: 19058593 [Abstract] [Full Text] [Related]
40. Erythropoietin response to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia. McGonigle RJ, Ohene-Frempong K, Lewy JE, Fisher JW. Acta Haematol; 1985 Jul; 74(1):6-9. PubMed ID: 3934912 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]